Thirty-seven patients with non-small cell carcinoma of the lung were randomized to receive doxorubicin, lomustine, hexamethylmelamine, and methotrexate (ACHM) or ACHM plus amphotericin B (AMB). The complete plus partial response rate was 39% for ACHM plus AMB, compared to 23% for ACHM alone. However, the median duration of complete or partial response was only 3.0 months with ACHM plus AMB, compared to 7.0 months with ACHM. Most importantly, median survival was only 4.0 months with ACHM plus AMB, compared to 8.0 months with ACHM (P = 0.08; two-tail test). Myelosuppression was enhanced by the addition of AMB. Although AMB has biological and antitumor activity in certain clinical circumstances, it does not appear to have a meaningful role in palliative therapy of patients with non-small cell bronchogenic carcinoma.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Longitudinal Assessment of OCT-Based Measures of Foveal Cone Structure in Achromatopsia.
Invest Ophthalmol Vis Sci
April 2024
Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
Purpose: Achromatopsia (ACHM) is an autosomal recessive retinal disease associated with reduced or absent cone function. There is debate regarding the extent to which cone structure shows progressive degeneration in patients with ACHM. Here, we used optical coherence tomography (OCT) images to evaluate outer nuclear layer (ONL) thickness and ellipsoid zone (EZ) integrity over time in individuals with ACHM.
View Article and Find Full Text PDFVTE Risk Assessment and Prevention in Pregnancy.
Hamostaseologie
June 2024
Rotunda Hospital, Dublin, Ireland.
Venous thromboembolism (VTE) remains the leading cause of maternal mortality in pregnancy and the postpartum period. In addition to the higher pregnancy-associated baseline VTE risk, there are several well-established risk factors that can further increase the risk of VTE. At present, a thorough interrogation of these risk factors remains our only tool for estimating which pregnant people may be at an increased risk of VTE, and thus potentially benefit from thromboprophylaxis.
View Article and Find Full Text PDFFirst-in-Human Gene Therapy Trial of AAV8-hCARp.hCNGB3 in Adults and Children With CNGB3-associated Achromatopsia.
Am J Ophthalmol
September 2023
From UCL Institute of Ophthalmology (M.M., N.H., S.Z., A.J.S., A.G.R., T.K., M.G., A.K., R.R.A., J.B.), London, United Kingdom; Moorfields Eye Hospital NHS Foundation Trust (M.M., N.H., S.C.W., S.Z., N.K., A.G.R., R.H.H., M.G., A.K., J.B.), London, United Kingdom.
Article Synopsis
- A clinical trial assessed the safety and effectiveness of AAV8-hCARp.hCNGB3 gene therapy in treating CNGB3-associated achromatopsia (ACHM) in 23 participants, including adults and children.
- Participants received varying doses of the treatment in their worst-seeing eye, with corticosteroids given to manage any inflammation.
- While the therapy showed an acceptable safety profile, with mild to moderate inflammation in some cases, there were individual improvements in color vision and quality of life, suggesting potential benefits warranting further research.
A deep intronic substitution in is one of the major causes of achromatopsia among Jewish patients.
Mol Vis
January 2022
Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Israel.
Purpose: Although most (or even all) genes that can cause achromatopsia (ACHM) when mutated are known, some patients are still negative for mutations even after screening the coding sequence of all known genes. Our aim was to characterize the genetic and clinical aspects of a deep intronic (c.1663-1205G>A, IVS14-1205G>A) variant.
View Article and Find Full Text PDFLongitudinal Assessment of Retinal Structure in Achromatopsia Patients With Long-Term Follow-up.
Invest Ophthalmol Vis Sci
December 2018
UCL Institute of Ophthalmology, University College London, London, United Kingdom.
Purpose: To longitudinally characterize structural retinal changes in achromatopsia (ACHM) over extended follow-up.
Methods: Fifty molecularly confirmed ACHM subjects underwent serial spectral-domain optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF) imaging. Foveal structure on SD-OCT was graded and compared for evidence of progression, and foveal total retinal thickness (FTRT) and outer nuclear layer (ONL) thickness were serially measured.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!